58755-57-0

Usage

Uses

Used in Chemical Synthesis:
2-Chloro-3-Nitrobenzaldehyde is used as a reagent for the synthesis of a variety of chemical products. Its reactivity and unique chemical properties make it a valuable component in the creation of new compounds.
Used in Biological Studies:
2-Chloro-3-Nitrobenzaldehyde is used as a research tool in biological studies, where its chemical properties can be explored for potential interactions with biological systems.
Used in Pharmaceutical Development:
2-Chloro-3-Nitrobenzaldehyde is used as a starting material or intermediate in the development of pharmaceuticals, where its unique structure may contribute to the creation of new drug candidates.
Used in Drug Delivery Systems:
In the pharmaceutical industry, 2-Chloro-3-Nitrobenzaldehyde is used as a component in the design of drug delivery systems, potentially improving the efficacy and bioavailability of certain medications.
Used in Material Science:
2-Chloro-3-Nitrobenzaldehyde is used in material science applications, where its chemical properties may contribute to the development of new materials with specific properties, such as improved stability or reactivity.

Upstream product

• 34915-64-5 C₈H₆ClNO₄ 
• 53663-14-2 anhydro-2-hydroxymercuri-3-nitrobenzoic acid 
• 3970-35-2 2-chloro-3-nitrobezoic acid 
• 3970-40-9 2-chloro-3-nitrotoluene 
• 89639-98-5 (2-chloro-3-nitrophenyl)methanol 

Downstream Products

• 22233-62-1 3,3'-Dinitro-2,2'-dichlor-desoxybenzoin 
• 77150-16-4 3-Nitro-2-(4-oxo-4H-quinazolin-3-yl)-benzaldehyde 
• 857040-81-4 2-(2-chloro-3-nitro-benzylamino)ethanol 
• 34084-89-4 7-nitro-benzo[b]thiophene-2-carboxylic acid methyl ester 
• 68064-95-9 2-[(2-chloro-3-nitrophenyl)methylene]-3-oxobutanoic acid, ethyl ester 

Relevant academic research and scientific papers

Visible-light assisted of nano Ni/g-C3N4 with efficient photocatalytic activity and stability for selective aerobic C?H activation and epoxidation

A selective, economical, and ecological protocol has been described for the oxidation of methyl arenes and their analogs to the corresponding carbonyl compounds and epoxidation reactions of alkenes with molecular oxygen (O2) or air as a green oxygen source, under mild reaction conditions. The nano Ni/g-C3N4 exhibited high photocatalytic activity, stability, and selectivity in the C?H activation of methyl arenes, methylene arenes, and epoxidation of various alkenes under visible- light irradiation without the use of an oxidizing agent and under base free conditions.

On/Off O2 Switchable Photocatalytic Oxidative and Protodecarboxylation of Carboxylic Acids

Photoredox catalysis in recent years has manifested a powerful branch of science in organic synthesis. Although merging photoredox and metal catalysts has been a widely used method, switchable heterogeneous photoredox catalysis has rarely been considered. Herein, we open a new window to use a switchable heterogeneous photoredox catalyst which could be turned on/off by changing a simple stimulus (O2) for two opponent reactions, namely, oxidative and protodecarboxylation. Using this strategy, we demonstrate that Au@ZnO core-shell nanoparticles could be used as a switchable photocatalyst which has good catalytic activity to absorb visible light due to the localized surface plasmon resonance effect of gold, can decarboxylate a wide range of aromatic and aliphatic carboxylic acids, have multiple reusability, and are a reasonable candidate for synthesizing both aldehydes/ketones and alkane/arenes in a large-scale set up. Some biologically active molecules are also shown via examples of the direct oxidative and protodecarboxylation which widely provided pharmaceutical agents.

Iterative design of a biomimetic catalyst for amino acid thioester condensation

Herein, the design of a catalyst that combines lessons learned from peptide biosynthesis, enzymes, and organocatalysts is described. The catalyst features a urea scaffold for carbonyl recognition and elements of nucleophilic catalysis. In the presence of 10 mol % of the organocatalyst, the rate of peptide bond formation is accelerated by 10000-fold over the uncatalyzed reaction between Fmoc-amino acid thioesters and amino acid methyl esters.

General synthetic strategies towards N-alkyl sulfoximine building blocks for medicinal chemistry and the use of dimethylsulfoximine as a versatile precursor

The sulfoximine group has great potential as a substituent in drug discovery, as evidenced by two new clinical candidates, and can be viewed as an isosteric alternative to the commonly used sulfone. Our aim was to improve the accessibility of this group by synthesising a diverse range of S-alkyl and N-alkyl sulfoximine building blocks with procedures that are applicable on a practical scale (>10 g). In particular, synthesis of the less well exploited N-alkyl sulfoximines and the use of dimethylsulfoximine as a versatile, commercially available precursor is discussed.

Novel pseudopeptides incorporating a benzodiazepine-based turn mimetic - Targeting Mycobacterium tuberculosis ribonucleotide reductase

Peptides mimicking the C-terminus of the small subunit (R2) of Mycobacterium tuberculosis ribonucleotide reductase (RNR) can compete for binding to the large subunit (R1) and thus inhibit RNR activity. Moreover, it has been suggested that the binding of t

OXO-HETEROCYCLIC SUBSTITUTED CARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF

The present application relates to novel carboxylic acid derivatives having an oxo-substituted azaheterocyclic partial structure, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for producing medicaments for the treatment and/or prophylaxis of diseases, especially for the treatment and/or prevention of cardiovascular disorders.

Carbazole inhibitors of histamine receptors for the treatment of disease

The present invention relates to carbazole compounds, pharmaceutical compositions comprising them, and methods which may be useful as inhibitors of H1R and/or H4R for the treatment or prevention of inflammatory, autoimmune, allergic, and ocular diseases.

New selective AT2 receptor ligands encompassing a γ-turn mimetic replacing the amino acid residues 4-5 of angiotensin II act as agonists

New benzodiazepine-based γ-turn mimetics with one or two amino acid side chains were synthesized. The γ-turn mimetics were incorporated into angiotensin II (Ang II) replacing the Val3-Tyr4-Ile 5 or Tyr4-Ile

Compounds useful in treating cytokine mediated diseases

Disclosed are amide compounds of formula(I): wherein Ar1, Q, Y and R3-R6 of formula(I) are defined herein. The compounds inhibit production of cytokines involved in inflammatory processes and are thus useful for treating d

4-Imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use

Compounds of formula I are useful in treating diseases prevented by or ameliorated with α1A agonists. Also disclosed are α1A agonist compositions and a method of activating α1 adrenoceptors in a mammal.